Skip to content

Comparing low dose (2500IU) and standard dose(5000IU) of arterial heparin on vascular complications following transradial coronary angiography

The effect of low dose (2500IU) versus standard dose(5000IU) of arterial heparin on vascular complications following transradial coronary angiography Randomized controlled clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201508174497N2
Enrollment
440
Registered
2015-09-15
Start date
2015-01-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Athrosclerosis. Atherosclerotic heart disease

Interventions

Intervention 1: 2500 IU heparin. Intervention 2: 5000 IU heparin.
Treatment - Drugs
2500 IU heparin
5000 IU heparin

Sponsors

Isfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: subjects older than 18 years old patients were scheduled for diagnostic coronary angiography candidte for proceed with radial access. Exclusion criteria: Patients were suggested to another arterial access site urgent angiography having bleeding disorders prior radial intervention pathological Allen tests chronic renal failure

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Thrombosis. Timepoint: Four and after 24 hours after intervention. Method of measurement: Radial pulse less investigated by color Doppler sonography.;Hemorrhage. Timepoint: Four and after 24 hours after intervention. Method of measurement: Observation.;Hematoma. Timepoint: Four and after 24 hours after intervention. Method of measurement: Observation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBabak Shirani

Medical School, Isfahan University of Medical Sciences

bsst1383@gmail.com+98 31 3337 7883

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026